Case report of extended survival and quality of life in a melanoma patient with multiple brain metastases and review of literature Journal Article uri icon
  • Long-term survival for melanoma patients with multiple brain metastases is rare. A review of the literature reveals only three reported melanoma patients with multiple brain metastases who survived more than 10 years. We present a patient who is recurrence-free 11 years after the diagnosis of three brain metastases. Her treatment consisted of cytokine (interferon and interleukin-2) and chemotherapy nine months prior to developing brain and soft tissue metastases, which were treated with stereotactic radiosurgery and stereotactic ablative radiotherapy, respectively, followed by six months of chemotherapy. Notably, she has not received any treatment for over 10 years, never underwent craniotomy or whole brain radiation therapy, currently has a perfect score on the functional assessment of cancer therapy for brain (FACT-Br) quality of life (QoL) scale, and runs marathons. This treatment course is consistent with emerging literature on the abscopal effect (radiation-induced immune response). Clinical trials are needed to better understand and harness the abscopal effect in order to optimally integrate targeted drug and radiation therapies.

  • Link to Article
    publication date
  • 2017
  • published in
  • Cureus  Journal
  • Research
  • Brain Cancer
  • Chemotherapy
  • Drugs and Drug Therapy
  • Quality of Life
  • Skin Cancer
  • Additional Document Info
  • 9
  • issue
  • 12